ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis. [PDF]
Pfister R +6 more
europepmc +1 more source
Multimorbidity, functional impairment and health-related quality of life in postural orthostatic tachycardia syndrome: findings from an Australian observational cohort study. [PDF]
Seeley MC +9 more
europepmc +1 more source
ABSTRACT Background Adult haematopoietic stem cell transplantation (HSCT) survivors have deficits in physical function, fatigue and quality of life that differ between autologous and allogeneic recipients. Few randomised controlled trials (RCTs) have evaluated exercise at 3 months or more, and immune reconstitution is rarely assessed.
Derek Dale Bayquen, Prahalad Narasimhan
wiley +1 more source
Anxiety and depression and their impact on functional recovery and quality of life in Guillain-Barré syndrome: a prospective cohort study in Bangladesh. [PDF]
Papri N +12 more
europepmc +1 more source
Abstract Background International statements suggest using the Global Leadership Initiative on Malnutrition (GLIM) criteria in intensive care units (ICUs); however, the economic impact of GLIM‐defined malnutrition in sepsis remains unclear. This study investigated the association between GLIM‐defined malnutrition and in‐hospital costs in sepsis ...
Yuki Hashimoto +38 more
wiley +1 more source
Baseline Graded Prognostic Assessment Is Associated with Postoperative Health-Related Quality of Life Recovery After Brain Metastasis Resection: A Prospective Cohort Study. [PDF]
Cetinkaya K +5 more
europepmc +1 more source
Safety and Effectiveness of a Bioabsorbable Septal Implant for Cartilaginous Nasal Septal Deviation
This study aims to evaluate the safety and effectiveness of a bioabsorbable submucosal septal implant (SeptAlign; Spirair Inc.) for minimally invasive correction of cartilaginous nasal septal deviation (NSD). In 80 subjects (92.5% with moderate‐to‐severe NSD), NOSE scores decreased by 63.2% (from 67.5 at baseline to 26.0 at 3 months and 23.6 at 6 ...
Thomas S. Higgins +7 more
wiley +1 more source
EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE. [PDF]
Augusto M +5 more
europepmc +1 more source
This pilot randomised feasibility trial evaluated the feasibility and acceptability of early, intensive home‐based pulmonary rehabilitation (PR) and high‐flow nasal oxygen (HFO) during exercise in patients with exertional hypoxaemia post‐hospitalisation. Early home‐based PR was feasible and safe.
Yingjuan Mok +11 more
wiley +1 more source

